What is Can Fite Biopharma Ltd ADR?
, a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 4.35M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.